[1] Chen PC, Muo CH, Lee YT, et al.Lung cancer and incidence of stroke: a population-based cohort study[J]. Stroke, 2011, 42(11): 3034-3039. [2] Alvarez-Perez FJ, Verde I, Uson-Martin M, et al.Frequency and mechanism of ischemic stroke associated with malignancy: a retrospective series[J]. Eur Neurol, 2012, 68(4): 209-213. [3] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志, 2015, 48(4): 246-257. [4] Adams HJ, Bendixen BH, Kappelle LJ, et al.Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment[J]. Stroke, 1993, 24(1): 35-41. [5] Kwon HM, Kang BS, Yoon BW.Stroke as the first manifestation of concealed cancer[J]. J Neurol Sci, 2007, 258(1-2): 80-83. [6] Kim SG, Hong JM, Kim HY, et al.Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea[J]. Stroke, 2010, 41(4): 798-801. [7] Schwarzbach CJ, Schaefer A, Ebert A, et al.Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology[J]. Stroke, 2012, 43(11): 3029-3034. [8] Navi BB, Singer S, Merkler AE, et al.Cryptogenic subtype predicts reduced survival among cancer patients with ischemic stroke[J]. Stroke, 2014, 45(8): 2292-2297. [9] Huang YS, Lee CC, Chang TS, et al.Increased risk of stroke in young head and neck cancer patients treated with radiotherapy or chemotherapy[J]. Oral Oncol, 2011, 47(11): 1092-1097. [10] Guo YJ, Chang MH, Chen PL, et al.Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective study[J]. J Stroke Cerebrovasc Dis, 2014, 23(4): e249-e254. [11] Kim JM, Jung KH, Park KH, et al.Clinical manifestation of cancer related stroke: retrospective case-control study[J]. J Neurooncol, 2013, 111(3): 295-301. [12] Zoller B, Ji J, Sundquist J, et al.Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden[J]. Eur J Cancer, 2012, 48(12): 1875-1883. [13] Borowski A, Ghodsizad A, Gams E.Stroke as a first manifestation of ovarian cancer[J]. J Neurooncol, 2005, 71(3): 267-269. [14] 孙葳,邢海英,彭清,等. 以急性多发性脑梗死为首发表现的隐匿性躯体恶性肿瘤12例报告[J]. 中国神经精神疾病杂志, 2016, 42(7): 385-389. [15] 张艳召,汪凯,张辉,等. 以急性脑梗死为首发表现的隐匿性恶性肿瘤患者13例临床特点总结[J]. 国际神经病学神经外科学杂志, 2017, 44(1): 58-62. [16] Zi WJ, Shuai J.Plasma D-dimer levels are associated with stroke subtypes and infarction volume in patients with acute ischemic stroke[J]. PLoS One, 2014, 9(1): e86465. [17] Cestari DM, Weine DM, Panageas KS, et al.Stroke in patients with cancer: incidence and etiology[J]. Neurology ,2004, 62(11): 2025-2030. [18] Seok JM, Kim SG, Kim JW, et al.Coagulopathy and embolic signal in cancer patients with ischemic stroke[J]. Ann Neurol, 2010, 68(2): 213-219. [19] Finelli PF, Nouh A.Three-territory DWI acute infarcts: diagnostic value in cancer-associated hypercoagulation stroke (Trousseau syndrome)[J]. Am J Neuroradiol, 2016, 37(11):2033-2036. [20] Lee MJ, Chung J, Ahn M, et al.Hypercoagulability and mortality of patients with stroke and active cancer: The OASIS-CANCER study[J]. J Stroke, 2017, 19(1): 77-87. [21] Nam K, Kim CK, Kim TJ, et al.Intravenous thrombolysis in acute ischemic stroke with active cancer[J]. Biomed Res Int, 2017, 2017: 1-5. |